News

As the FDA approved a new targeted therapy for metastatic pancreatic cancer, an early-stage Columbia trial offers another encouraging signal that one of cancer’s most stubborn diseases may be entering a new era of treatment.

How a once-impenetrable tumor is seeing its walls crumble

Homemade breakfast bars without sugar, Merrells in the OR, and a garden that requires daily intent, a routine rooted in patience, first.

An interview with John A. Chabot, MD, Chief of the Division of GI/Endocrine Surgery and Executive Director of the Pancreas Center, about the latest in pancreatic care.

In our newest episode of Dr. AI, pancreatic surgeon Dr. Beth Schrope challenges ChatGPT with a medical question.

Over a 40-year career, this surgeon and chief has found work/life balance in the middle of his garden.

We are honored to announce a call for nominations for the 12th annual Ruth Leff Siegel Award for Excellence in Pancreatic Cancer Research. The Pancreas Center at Columbia University and The Herbert Irving Comprehensive Cancer Center have been entrusted by the Siegel family to identify the investigator who has made the most impactful contribution to the understanding and/or treatment of pancreatic cancer over the past year.

Study of AI’s ability to diagnose pancreatic cancer: John A. Chabot, MD, Executive Director of The Pancreas Center speaks about this study and where we go now.